Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 782

1.

Systematic review of differential methylation in rare ophthalmic diseases.

Kerr K, McAneney H, Smyth L, Flanagan C, Silvestri J, Nesbitt MA, Wooster C, McKnight AJ.

BMJ Open Ophthalmol. 2019 Nov 13;4(1):e000342. doi: 10.1136/bmjophth-2019-000342. eCollection 2019. Review.

2.

Stability of anticholinergic load in Australian community-dwelling older people: a longitudinal analysis.

Mate KE, Barnett M, Kerr KP, Pond CD, Magin PJ.

Fam Pract. 2019 Nov 30. pii: cmz076. doi: 10.1093/fampra/cmz076. [Epub ahead of print]

PMID:
31784733
3.

Inter-observer Reliability of Programmed Cell Death Ligand-1 Scoring Using the VENTANA PD-L1 (SP263) Assay in Non-Small Cell Lung Cancer.

Williams GH, Nicholson AG, Snead DRJ, Thunnissen E, Lantuejoul S, Cane P, Kerr KM, Loddo M, Scott MLJ, Scorer PW, Barker C.

J Thorac Oncol. 2019 Nov 25. pii: S1556-0864(19)33664-0. doi: 10.1016/j.jtho.2019.11.010. [Epub ahead of print]

PMID:
31778799
4.

Always on my mind: Cross-brain associations of mental health symptoms during simultaneous parent-child scanning.

Cosgrove KT, Kerr KL, Aupperle RL, Ratliff EL, DeVille DC, Silk JS, Burrows K, Moore AJ, Antonacci C, Misaki M, Tapert SF, Bodurka J, Simmons WK, Morris AS.

Dev Cogn Neurosci. 2019 Nov 5;40:100729. doi: 10.1016/j.dcn.2019.100729. [Epub ahead of print]

5.

Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort.

Thunnissen E, Kerr KM, Dafni U, Bubendorf L, Finn SP, Soltermann A, Biernat W, Cheney R, Verbeken E, Warth A, Marchetti A, Speel EM, Pokharel S, Quinn AM, Monkhorst K, Navarro A, Madsen LB, Tsourti Z, Geiger T, Kammler R, Peters S, Stahel RA; European Thoracic Oncology Platform Lungscape Consortium.

Mod Pathol. 2019 Nov 18. doi: 10.1038/s41379-019-0383-9. [Epub ahead of print]

PMID:
31740722
6.

Genetic Strategies to Understand Human Diabetic Nephropathy: In Silico Strategies for Molecular Data-Association Studies.

Canadas-Garre M, Smyth LJ, Anderson K, Kerr K, McKnight AJ.

Methods Mol Biol. 2020;2067:241-275. doi: 10.1007/978-1-4939-9841-8_16.

PMID:
31701456
7.

Genetic Strategies to Understand Human Diabetic Nephropathy: Wet-Lab Approaches.

Smyth LJ, Kerr K, Duffy S, Kilner J, McKnight AJ.

Methods Mol Biol. 2020;2067:205-240. doi: 10.1007/978-1-4939-9841-8_15.

PMID:
31701455
8.

Quantifying Donor Effects on Transplant Outcomes Using Kidney Pairs from Deceased Donors.

Kerr KF, Morenz ER, Thiessen-Philbrook H, Coca SG, Wilson FP, Reese PP, Parikh CR.

Clin J Am Soc Nephrol. 2019 Nov 1. pii: CJN.03810319. doi: 10.2215/CJN.03810319. [Epub ahead of print]

PMID:
31676539
9.

A Detoxification Intervention for Gulf War Illness: A Pilot Randomized Controlled Trial.

Kerr K, Morse G, Graves D, Zuo F, Lipowicz A, Carpenter DO.

Int J Environ Res Public Health. 2019 Oct 28;16(21). pii: E4143. doi: 10.3390/ijerph16214143.

10.

Appetite change profiles in depression exhibit differential relationships between systemic inflammation and activity in reward and interoceptive neurocircuitry.

Cosgrove KT, Burrows K, Avery JA, Kerr KL, DeVille DC, Aupperle RL, Teague TK, Drevets WC, Simmons WK.

Brain Behav Immun. 2019 Oct 8. pii: S0889-1591(19)30253-3. doi: 10.1016/j.bbi.2019.10.006. [Epub ahead of print]

PMID:
31604141
11.

Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.

Piepkorn MW, Longton GM, Reisch LM, Elder DE, Pepe MS, Kerr KF, Tosteson ANA, Nelson HD, Knezevich S, Radick A, Shucard H, Onega T, Carney PA, Elmore JG, Barnhill RL.

JAMA Netw Open. 2019 Oct 2;2(10):e1912597. doi: 10.1001/jamanetworkopen.2019.12597.

12.

Ramelteon for Prevention of Postoperative Delirium: A Randomized Controlled Trial in Patients Undergoing Elective Pulmonary Thromboendarterectomy.

Jaiswal SJ, Vyas AD, Heisel AJ, Ackula H, Aggarwal A, Kim NH, Kerr KM, Madani M, Pretorius V, Auger WR, Fernandes TM, Malhotra A, Owens RL.

Crit Care Med. 2019 Dec;47(12):1751-1758. doi: 10.1097/CCM.0000000000004004.

PMID:
31567351
13.

Parental influences on neural mechanisms underlying emotion regulation.

Kerr KL, Ratliff EL, Cosgrove KT, Bodurka J, Morris AS, Kyle Simmons W.

Trends Neurosci Educ. 2019 Sep;16:100118. doi: 10.1016/j.tine.2019.100118. Epub 2019 Jul 20. Review.

PMID:
31540673
14.

Neuraminidase 1 regulates proliferation, apoptosis and the expression of Cadherins in mammary carcinoma cells.

Thulasiraman P, Kerr K, McAlister K, Hardisty S, Wistner A, McCullough I.

Mol Cell Biochem. 2019 Dec;462(1-2):207-215. doi: 10.1007/s11010-019-03623-7. Epub 2019 Sep 12.

PMID:
31515676
15.

Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization.

Huang RSP, Smith D, Le CH, Liu WW, Ordinario E, Manohar C, Lee M, Rajamani J, Truong H, Li J, Choi C, Li J, Pati A, Bubendorf L, Buettner R, Kerr KM, Lopez-Rios F, Marchetti A, Marondel I, Nicholson AG, Öz AB, Pauwels P, Penault-Llorca F, Rossi G, Thunnissen E, Newell AH, Pate G, Menzl I.

Arch Pathol Lab Med. 2019 Sep 11. doi: 10.5858/arpa.2019-0085-OA. [Epub ahead of print]

PMID:
31509456
16.

Transition probabilities for clinical trials: investigating individual diseases.

Miller KL, Rabinovitz D, Kerr KW.

Nat Rev Drug Discov. 2019 Sep;18(9):658. doi: 10.1038/d41573-019-00124-6. No abstract available.

PMID:
31477856
17.

Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia model.

Xu H, Muise ES, Javaid S, Chen L, Cristescu R, Mansueto MS, Follmer N, Cho J, Kerr K, Altura R, Machacek M, Nicholson B, Addona G, Kariv I, Chen H.

J Cell Mol Med. 2019 Oct;23(10):7063-7077. doi: 10.1111/jcmm.14608. Epub 2019 Aug 26.

18.

Differential methylation as a diagnostic biomarker of rare renal diseases: a systematic review.

Kerr K, McAneney H, Flanagan C, Maxwell AP, McKnight AJ.

BMC Nephrol. 2019 Aug 16;20(1):320. doi: 10.1186/s12882-019-1517-5.

19.

Variants Associated with the Ankle Brachial Index Differ by Hispanic/Latino Ethnic Group: a genome-wide association study in the Hispanic Community Health Study/Study of Latinos.

Sofer T, Emery L, Jain D, Ellis AM, Laurie CC, Allison MA, Lee J, Kurniansyah N, Kerr KF, González HM, Tarraf W, Criqui MH, Lange LA, Palmas WR, Franceschini N, Wassel CL.

Sci Rep. 2019 Aug 6;9(1):11410. doi: 10.1038/s41598-019-47928-5.

20.

Widespread drought-induced tree mortality at dry range edges indicates that climate stress exceeds species' compensating mechanisms.

Anderegg WRL, Anderegg LDL, Kerr KL, Trugman AT.

Glob Chang Biol. 2019 Nov;25(11):3793-3802. doi: 10.1111/gcb.14771. Epub 2019 Aug 13.

PMID:
31323157
21.

Canine circoviral hemorrhagic enteritis in a dog in Connecticut.

Van Kruiningen HJ, Heishima M, Kerr KM, Garmendia AE, Helal Z, Smyth JA.

J Vet Diagn Invest. 2019 Sep;31(5):732-736. doi: 10.1177/1040638719863102. Epub 2019 Jul 10.

PMID:
31291838
22.

GWAS of QRS duration identifies new loci specific to Hispanic/Latino populations.

Swenson BR, Louie T, Lin HJ, Méndez-Giráldez R, Below JE, Laurie CC, Kerr KF, Highland H, Thornton TA, Ryckman KK, Kooperberg C, Soliman EZ, Seyerle AA, Guo X, Taylor KD, Yao J, Heckbert SR, Darbar D, Petty LE, McKnight B, Cheng S, Bello NA, Whitsel EA, Hanis CL, Nalls MA, Evans DS, Rotter JI, Sofer T, Avery CL, Sotoodehnia N.

PLoS One. 2019 Jun 28;14(6):e0217796. doi: 10.1371/journal.pone.0217796. eCollection 2019.

23.

An Analysis of Follow-On Development in New Drug Classes, January 1986-June 2018.

Lanthier ML, Kerr KW, Miller KL.

Clin Pharmacol Ther. 2019 Nov;106(5):1125-1132. doi: 10.1002/cpt.1554. Epub 2019 Jul 26.

PMID:
31206617
24.

Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.

Ioannou GN, Green P, Kerr KF, Berry K.

J Hepatol. 2019 Sep;71(3):523-533. doi: 10.1016/j.jhep.2019.05.008. Epub 2019 May 28.

PMID:
31145929
25.

The Importance of Uncertainty and Opt-In v. Opt-Out: Best Practices for Decision Curve Analysis.

Kerr KF, Marsh TL, Janes H.

Med Decis Making. 2019 Jul;39(5):491-492. doi: 10.1177/0272989X19849436. Epub 2019 May 20. No abstract available.

PMID:
31104561
26.

Using ordinal outcomes to construct and select biomarker combinations for single-level prediction.

Meisner A, Parikh CR, Kerr KF.

Diagn Progn Res. 2018 May 21;2:8. doi: 10.1186/s41512-018-0028-3. eCollection 2018.

27.

Protocol for a scoping review of multi-omic analysis for rare diseases.

Kerr K, McAneney H, McKnight AJ.

BMJ Open. 2019 May 5;9(5):e026278. doi: 10.1136/bmjopen-2018-026278.

28.

Exceptional preservation of mid-Cretaceous marine arthropods and the evolution of novel forms via heterochrony.

Luque J, Feldmann RM, Vernygora O, Schweitzer CE, Cameron CB, Kerr KA, Vega FJ, Duque A, Strange M, Palmer AR, Jaramillo C.

Sci Adv. 2019 Apr 24;5(4):eaav3875. doi: 10.1126/sciadv.aav3875. eCollection 2019 Apr.

29.

A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project.

Kerr KM, Thunnissen E, Dafni U, Finn SP, Bubendorf L, Soltermann A, Verbeken E, Biernat W, Warth A, Marchetti A, Speel EM, Pokharel S, Quinn AM, Monkhorst K, Navarro A, Madsen LB, Radonic T, Wilson J, De Luca G, Gray SG, Cheney R, Savic S, Martorell M, Muley T, Baas P, Meldgaard P, Blackhall F, Dingemans AM, Dziadziuszko R, Vansteenkiste J, Weder W, Polydoropoulou V, Geiger T, Kammler R, Peters S, Stahel R; Lungscape Consortium.

Lung Cancer. 2019 May;131:95-103. doi: 10.1016/j.lungcan.2019.03.012. Epub 2019 Mar 15.

PMID:
31027705
30.

Communication strategies for rare cancers: a systematic review protocol.

Bell C, Kerr K, Moore K, McShane C, Anderson L, McKnight AJ, McAneney H.

Syst Rev. 2019 Apr 23;8(1):102. doi: 10.1186/s13643-019-1017-5.

31.

Differential methylation in rare ophthalmic disorders: a systematic review protocol.

Kerr K, McAneney H, McKnight AJ.

Syst Rev. 2019 Apr 10;8(1):93. doi: 10.1186/s13643-019-0999-3.

32.

Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers.

Stewart T, Shi M, Mehrotra A, Aro P, Soltys D, Kerr KF, Zabetian CP, Peskind ER, Taylor P, Shaw LM, Trojanowski JQ, Zhang J; and from the Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2019;69(1):263-276. doi: 10.3233/JAD-190069.

33.

Redefining Treatment Paradigms in First-line Advanced Non-Small-Cell Lung Cancer.

Heigener DF, Kerr KM, Laing GM, Mok TSK, Moiseyenko FV, Reck M.

Clin Cancer Res. 2019 Aug 15;25(16):4881-4887. doi: 10.1158/1078-0432.CCR-18-1894. Epub 2019 Mar 25. Review.

PMID:
30910855
34.

Atrial arrhythmias after pulmonary thromboendarterectomy.

Farasat S, Papamatheakis DG, Poch DS, Higgins J, Pretorius VG, Madani MM, Auger WR, Kerr KM, Fernandes TM.

J Card Surg. 2019 May;34(5):312-317. doi: 10.1111/jocs.14028. Epub 2019 Mar 25.

PMID:
30908728
35.

Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?

Reck M, Kerr KM, Grohé C, Manegold C, Pavlakis N, Paz-Ares L, Huber RM, Popat S, Thatcher N, Park K, Hilberg F, Barrueco J, Kaiser R.

Future Oncol. 2019 Apr;15(12):1363-1383. doi: 10.2217/fon-2018-0948. Epub 2019 Feb 13. Review.

36.

Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC.

Camidge DR, Doebele RC, Kerr KM.

Nat Rev Clin Oncol. 2019 Jun;16(6):341-355. doi: 10.1038/s41571-019-0173-9. Review.

PMID:
30718843
37.

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S.

Ann Oncol. 2019 May 1;30(5):863-870. doi: 10.1093/annonc/mdy474. No abstract available.

PMID:
30715168
38.

Impairment of Inhibition of Trigeminal Nociception via Conditioned Pain Modulation in Persons with Migraine Headaches.

Williams AE, Miller MM, Bartley EJ, McCabe KM, Kerr KL, Rhudy JL.

Pain Med. 2019 Jan 25. doi: 10.1093/pm/pny305. [Epub ahead of print]

PMID:
30690591
39.

Assessing the Clinical Impact of Risk Models for Opting Out of Treatment.

Kerr KF, Brown MD, Marsh TL, Janes H.

Med Decis Making. 2019 Feb;39(2):86-90. doi: 10.1177/0272989X18819479. Epub 2019 Jan 16.

PMID:
30649998
40.

Characterization of the Myocardial Inflammatory Response in Acute Stress-Induced (Takotsubo) Cardiomyopathy.

Wilson HM, Cheyne L, Brown PAJ, Kerr K, Hannah A, Srinivasan J, Duniak N, Horgan G, Dawson DK.

JACC Basic Transl Sci. 2018 Dec 31;3(6):766-778. doi: 10.1016/j.jacbts.2018.08.006. eCollection 2018 Dec.

41.

Implementing the Emergency Severity Index Triage System in Jamaican Accident and Emergency Departments.

French S, Gordon-Strachan G, Kerr K, Bisasor-McKenzie J, Innis L, Tanabe P.

J Emerg Nurs. 2019 Mar;45(2):124-131. doi: 10.1016/j.jen.2018.11.010. Epub 2018 Dec 24. No abstract available.

PMID:
30591242
42.

Domestic and Family Violence, Reproductive Coercion and the Role for Law.

Douglas H, Kerr K.

J Law Med. 2018 Dec;26(2):341-355.

PMID:
30574723
43.

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.

Yatabe Y, Dacic S, Borczuk AC, Warth A, Russell PA, Lantuejoul S, Beasley MB, Thunnissen E, Pelosi G, Rekhtman N, Bubendorf L, Mino-Kenudson M, Yoshida A, Geisinger KR, Noguchi M, Chirieac LR, Bolting J, Chung JH, Chou TY, Chen G, Poleri C, Lopez-Rios F, Papotti M, Sholl LM, Roden AC, Travis WD, Hirsch FR, Kerr KM, Tsao MS, Nicholson AG, Wistuba I, Moreira AL.

J Thorac Oncol. 2019 Mar;14(3):377-407. doi: 10.1016/j.jtho.2018.12.005. Epub 2018 Dec 18.

PMID:
30572031
44.

Use of Anticoagulation Agents After Traumatic Intracranial Hemorrhage.

Divito A, Kerr K, Wilkerson C, Shepard S, Choi A, Kitagawa RS.

World Neurosurg. 2019 Mar;123:e25-e30. doi: 10.1016/j.wneu.2018.10.173. Epub 2018 Dec 6.

PMID:
30528524
45.

Case Study Investigation Decreases Burnout While Improving Interprofessional Teamwork, Nurse Satisfaction, and Patient Safety.

Hellyar M, Madani C, Yeaman S, OʼConnor K, Kerr KM, Davidson JE.

Crit Care Nurs Q. 2019 Jan/Mar;42(1):96-105. doi: 10.1097/CNQ.0000000000000243.

PMID:
30507670
46.

Erratum for Schooley et al., "Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection".

Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e02221-18. doi: 10.1128/AAC.02221-18. Print 2018 Dec. No abstract available.

47.

Use of cardiopulmonary exercise testing in the perioperative period. Comment on Br J Anaesth 2018; 121: 496-7.

Kerr K, Mannings A, Kojro A, Wagstaff K, Whitaker J.

Br J Anaesth. 2018 Dec;121(6):1364-1365. doi: 10.1016/j.bja.2018.09.007. Epub 2018 Oct 19. No abstract available.

48.

Genome-wide association reveals contribution of MRAS to painful temporomandibular disorder in males.

Smith SB, Parisien M, Bair E, Belfer I, Chabot-Doré AJ, Gris P, Khoury S, Tansley S, Torosyan Y, Zaykin DV, Bernhardt O, de Oliveira Serrano P, Gracely RH, Jain D, Järvelin MR, Kaste LM, Kerr KF, Kocher T, Lähdesmäki R, Laniado N, Laurie CC, Laurie CA, Männikkö M, Meloto CB, Nackley AG, Nelson SC, Pesonen P, Ribeiro-Dasilva MC, Rizzatti-Barbosa CM, Sanders AE, Schwahn C, Sipilä K, Sofer T, Teumer A, Mogil JS, Fillingim RB, Greenspan JD, Ohrbach R, Slade GD, Maixner W, Diatchenko L.

Pain. 2019 Mar;160(3):579-591. doi: 10.1097/j.pain.0000000000001438.

49.

Open Surgery for Extraction of an Embolized Pellet in the Middle Cerebral Artery From a Shotgun Injury.

Monterey M, Kerr K, Dannenbaum M, Chen PR, Blackburn S.

Oper Neurosurg (Hagerstown). 2019 Sep 1;17(3):E119-E123. doi: 10.1093/ons/opy312.

PMID:
30423149
50.

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD, Peters S; ESMO Guidelines Committee.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275. No abstract available.

Supplemental Content

Support Center